These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26045875)

  • 1. Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis".
    Liu F; Zhou D; Zhang Q; Wang B
    Int J Clin Exp Pathol; 2015; 8(3):3384-5. PubMed ID: 26045875
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis".
    Yan MM; Ni JD
    Int J Clin Exp Pathol; 2015; 8(6):7617-8. PubMed ID: 26261680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
    Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
    Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
    Zhang Q; Li J; Liu F; Li Z
    Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
    Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
    Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16INK4a overexpression is associated with poor clinical outcome in ovarian carcinoma.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei GL
    J Chemother; 2004 Aug; 16(4):411-3. PubMed ID: 15332720
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
    Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
    Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
    Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4a expression in invasive vulvar squamous cell carcinoma.
    Tringler B; Grimm C; Dudek G; Zeillinger R; Tempfer C; Speiser P; Joura E; Reinthaller A; Hefler LA
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):279-83. PubMed ID: 17721272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines.
    Agiostratidou G; Derventzi A; Gonos ES
    In Vivo; 2001; 15(5):443-6. PubMed ID: 11695244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical issues in the application of p16 immunohistochemistry in diagnostic pathology.
    Mahajan A
    Hum Pathol; 2016 May; 51():64-74. PubMed ID: 27067784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonectin in osteosarcomas: a marker for differential diagnosis and/or prognosis?
    Wuisman P; Roessner A; Bosse A; Ueda Y; Winkelmann W; Enneking WF
    Ann Oncol; 1992 Apr; 3 Suppl 2():S33-5. PubMed ID: 1622861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens.
    Scotlandi K; Serra M; Landuzzi L; Baldini N
    Ann Oncol; 1992 Apr; 3 Suppl 2():S29-31. PubMed ID: 1622859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.